Literature DB >> 2331769

Positron emission tomographic imaging of cardiac sympathetic innervation and function.

D S Goldstein1, P C Chang, G Eisenhofer, R Miletich, R Finn, J Bacher, K L Kirk, S Bacharach, I J Kopin.   

Abstract

Sites of uptake, storage, and metabolism of [18F]fluorodopamine and excretion of [18F]fluorodopamine and its metabolites were visualized using positron emission tomographic (PET) scanning after intravenous injection of the tracer into anesthetized dogs. Radioactivity was concentrated in the renal pelvis, heart, liver, spleen, salivary glands, and gall bladder. Uptake of 18F by the heart resulted in striking delineation of the left ventricular myocardium. Pretreatment with desipramine markedly decreased cardiac positron emission, consistent with dependence of the heart on neuronal uptake (uptake-1) for removal of circulating catecholamines. In reserpinized animals, cardiac positron emission was absent within 30 minutes after injection of [18F]-6-fluorodopamine, demonstrating that the emission in untreated animals was from radioactive labeling of the sympathetic storage vesicles. Decreased positron emission from denervated salivary glands confirmed that the tracer was concentrated in sympathetic neurons. Radioactivity in the gall bladder and urinary system depicted the hepatic and renal excretion of the tracer and its metabolites. Administration of tyramine or nitroprusside increased and ganglionic blockade with trimethaphan decreased the rate of loss of myocardial radioactivity. The results show that PET scanning after administration of [18F]fluorodopamine can be used to visualize sites of sympathetic innervation, follow the metabolism and renal and hepatic excretion of catecholamines, and examine cardiac sympathetic function.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2331769     DOI: 10.1161/01.cir.81.5.1606

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  23 in total

Review 1.  Brain, behavior, mental stress, and the neurocardiac interaction.

Authors:  Robert Soufer; James A Arrighi; Matthew M Burg
Journal:  J Nucl Cardiol       Date:  2002 Nov-Dec       Impact factor: 5.952

Review 2.  Sympathetic deactivation as a goal of nonpharmacologic and pharmacologic antihypertensive treatment: rationale and options.

Authors:  Guido Grassi
Journal:  Curr Hypertens Rep       Date:  2003-08       Impact factor: 5.369

Review 3.  Cardiac neuronal imaging: application in the evaluation of cardiac disease.

Authors:  Maureen M Henneman; Frank M Bengel; Ernst E van der Wall; Juhani Knuuti; Jeroen J Bax
Journal:  J Nucl Cardiol       Date:  2008-04-16       Impact factor: 5.952

4.  Patients as a scientific resource: comments on receiving the Ahrens award.

Authors:  David S Goldstein
Journal:  Clin Transl Sci       Date:  2011-08       Impact factor: 4.689

Review 5.  Imaging the Autonomic Nervous System in Parkinson's Disease.

Authors:  Karoline Knudsen; Per Borghammer
Journal:  Curr Neurol Neurosci Rep       Date:  2018-09-19       Impact factor: 5.081

6.  First-in-Human Studies of [18F] Fluorohydroxyphenethylguanidines.

Authors:  David M Raffel; Yong-Woon Jung; Robert A Koeppe; Keun Sam Jang; Guie Gu; Peter J H Scott; Venkatesh L Murthy; Jill Rothley; Kirk A Frey
Journal:  Circ Cardiovasc Imaging       Date:  2018-12       Impact factor: 7.792

Review 7.  Rationale for the rational development of new cardiac imaging agents.

Authors:  D D Miller
Journal:  Ann Nucl Med       Date:  1993-11       Impact factor: 2.668

Review 8.  Cardiac sympathetic neuronal imaging using PET.

Authors:  Riikka Lautamäki; Dnyanesh Tipre; Frank M Bengel
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-06       Impact factor: 9.236

9.  Regional distribution and kinetics of [18F]6-flurodopamine as a measure of cardiac sympathetic activity in humans.

Authors:  G Coates; R Chirakal; E L Fallen; G Firnau; E S Garnett; M V Kamath; A Scheffel; C Nahmias
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

Review 10.  Assessment of cardiac sympathetic neuronal function using PET imaging.

Authors:  Frank M Bengel; Markus Schwaiger
Journal:  J Nucl Cardiol       Date:  2004 Sep-Oct       Impact factor: 5.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.